<DOC>
	<DOCNO>NCT02977832</DOCNO>
	<brief_summary>Odyliresin ( Iresine Celosia ) cytochrome-flavoprotein powerful anti-oxydant action cell , therapeutic effect BPH-related LUTS , reduce symptom , prostate volume , improve patient 's quality life eventually limiting number patient require surgery endoscopy medical treatment .</brief_summary>
	<brief_title>Clinical Results Odyliresin ( Iresine Celosia ) Symptomatic Benign Prostatic Hyperplasia</brief_title>
	<detailed_description>The aim phase II open clinical trial determine Odyliresin , give unique chemical structure , therapeutic effect BPH-related LUTS , reduce symptom , prostate volume , improve patient 's quality life eventually limit number patient require surgery endoscopy medical treatment . To aim , patient seek specialist advice LUTS previous surgical treatment BPH select treatment Odyliresin addition alpha-antagonist , order determine whether 12 month clinical result obtain , 6 12 month BPH symptom significantly improve , reduction prostatic volume observe , thus change usual course disease . All patient BPH-related LUTS receive alphalitic Odyliresin treatment , clinical parameter uroflowmetry parameter significantly improve , adenoma volume post-void residual volume significantly reduce 12 month . This first clinical experience Iresine Celosia BPH .</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Alfuzosin</mesh_term>
	<criteria>45 year age old Clinically diagnose mild moderate BPH Prostatic volume â‰¥ 30 ml determine transrectal ultrasound Maximum flow rate ( Qmax ) &lt; 15 ml/sec void volume 150500 ml Participants must severe BPH ( IPSS symptom score &gt; 21 ) Participants currently undergo form medical therapy BPH ( 5PDE inhibitor , mepartricine , plant extract Saw Palmetto , vitamin E , quercetin ) . Patients must undergo prior transurethral resection prostate ( TURP ) . Post void residual ( PVD ) &gt; 200 ml Previous urological history include urethral stricture disease and/or bladder neck disease , urinary retention , bladder stone , chronic prostatitis , bladder cancer , interstitial cystitis , active upper tract stone disease cause symptom , insulindependent diabetes mellitus noncontrolled noninsulindependent diabetes mellitus , chronic renal failure</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>LUTS</keyword>
	<keyword>Iresine celosia</keyword>
	<keyword>Odyliresin</keyword>
	<keyword>medical therapy</keyword>
</DOC>